Literature DB >> 12917854

A randomized controlled trial of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disease.

Dagoberto V de Godoy1, Rossane F de Godoy.   

Abstract

OBJECTIVE: To assess the effect of psychotherapy on the anxiety and depression levels of patients with chronic obstructive pulmonary disease (COPD).
DESIGN: A blind, randomized, controlled trial.
SETTING: Outpatient university pulmonary rehabilitation program in Brazil. PARTICIPANTS: Thirty patients with COPD (mean age, 60.33y; 22 men) attending a pulmonary rehabilitation program were randomized into 2 groups: experimental group (G1) and control group (G2). Both groups underwent a 12-week treatment program.
INTERVENTIONS: Group 1 (n=14) participated in 24 sessions of physical exercise, 24 sessions of physiotherapy, 12 psychologic sessions, and 3 educational sessions. Group 2 did not participate in psychotherapy sessions. MAIN OUTCOME MEASURES: All patients were evaluated at baseline and at completion of the pulmonary rehabilitation program by using 3 instruments: the Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI), and 6-minute walk distance (6MWD).
RESULTS: Both groups showed statistically significant improvements on the 6MWD (G1, P<.001; G2, P=.03). Only G1 had a significant reduction in anxiety and depression levels (G1: BAI, P<.001; BDI, P<.001; G2: BAI, P=.156; BDI, P=.142). Statistically significant differences existed between G1 and G2 for BAI (P<.001) and BDI (P=.02).
CONCLUSIONS: Including psychotherapy in a pulmonary rehabilitation program for COPD reduced patients' anxiety and depression levels but did not modify 6MWD performance.

Entities:  

Mesh:

Year:  2003        PMID: 12917854     DOI: 10.1016/s0003-9993(03)00239-9

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  35 in total

1.  Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: a cross-sectional study.

Authors:  Nicholas D Giardino; Jeffrey L Curtis; Adin-Cristian Andrei; Vincent S Fan; Joshua O Benditt; Mark Lyubkin; Keith Naunheim; Gerard Criner; Barry Make; Robert A Wise; Susan K Murray; Alfred P Fishman; Frank C Sciurba; Israel Liberzon; Fernando J Martinez
Journal:  Respir Res       Date:  2010-03-09

2.  Models of care for late-life depression of the medically ill: examples from chronic obstructive pulmonary disease and stroke.

Authors:  Jimmy N Avari; George S Alexopoulos
Journal:  Am J Geriatr Psychiatry       Date:  2014-06-20       Impact factor: 4.105

3.  The effects of a telehealth coping skills intervention on outcomes in chronic obstructive pulmonary disease: primary results from the INSPIRE-II study.

Authors:  James A Blumenthal; Charles F Emery; Patrick J Smith; Francis J Keefe; Karen Welty-Wolf; Stephanie Mabe; Tereza Martinu; Julie J Johnson; Michael A Babyak; Virginia F O'Hayer; Philip T Diaz; Michael Durheim; Donald Baucom; Scott M Palmer
Journal:  Psychosom Med       Date:  2014-10       Impact factor: 4.312

Review 4.  Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease.

Authors:  Zafar A Usmani; Kristin V Carson; Karen Heslop; Adrian J Esterman; Anthony De Soyza; Brian J Smith
Journal:  Cochrane Database Syst Rev       Date:  2017-03-21

Review 5.  Depression in the patient with COPD.

Authors:  Ian Wilson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

Review 6.  Anxiety and depression in COPD: current understanding, unanswered questions, and research needs.

Authors:  Janet Maurer; Venkata Rebbapragada; Soo Borson; Roger Goldstein; Mark E Kunik; Abebaw M Yohannes; Nicola A Hanania
Journal:  Chest       Date:  2008-10       Impact factor: 9.410

7.  Caregiver-assisted coping skills training for patients with COPD: background, design, and methodological issues for the INSPIRE-II study.

Authors:  James A Blumenthal; Francis J Keefe; Michael A Babyak; C Virginia Fenwick; Julie M Johnson; Kylie Stott; Rachel K Funk; Meredith J McAdams; Scott Palmer; Tereza Martinu; Don Baucom; Philip T Diaz; Charles F Emery
Journal:  Clin Trials       Date:  2009-04       Impact factor: 2.486

8.  Discriminant validity of the Hospital Anxiety and Depression Scale, Beck Depression Inventory (II) and Beck Anxiety Inventory to confirmed clinical diagnosis of depression and anxiety in patients with chronic obstructive pulmonary disease.

Authors:  Tina Phan; Owen Carter; Claire Adams; Grant Waterer; Li Ping Chung; Maxine Hawkins; Cobie Rudd; Mel Ziman; Natalie Strobel
Journal:  Chron Respir Dis       Date:  2016-03-03       Impact factor: 2.444

Review 9.  Depression in COPD--management and quality of life considerations.

Authors:  Kurt B Stage; Thomas Middelboe; Tore B Stage; Claus H Sørensen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

10.  More evidence that depressive symptoms predict mortality in COPD patients: is type D personality an alternative explanation?

Authors:  Jacob N de Voogd; Johan B Wempe; Klaas Postema; Eric van Sonderen; Adelita V Ranchor; James C Coyne; Robbert Sanderman
Journal:  Ann Behav Med       Date:  2009-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.